ScripU. Of Texas Research Branch Maintains Hectic Partnering Pace The increasingly busy University of Texas MD Anderson Cancer Center inked three new alliances with biopharmaceutical companies in the pas
ScripVor Hopes NCI’s CAR-T Candidate Is Synergistic With Lead AML Therapy PureTech Health plc -backed Vor Biopharma Inc. said on 11 November that it has licensed a clinical-stage chimeric antigen recept